[Marked hematologic improvement despite deterioration of marrow cell dysplasia in a refractory anemia patient treated with vitamin D3]

MLA

N, Wakimoto, et al. “[Marked Hematologic Improvement despite Deterioration of Marrow Cell Dysplasia in a Refractory Anemia Patient Treated with Vitamin D3].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, vol. 40, no. 5, July 1999. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........0529eea8ffe6c864acf3621ec7978882&authtype=sso&custid=ns315887.

APA

N, W., F, K., K, S., N, K., T, M., T, Y., Y, N., M, Y., & K, M. (1999). [Marked hematologic improvement despite deterioration of marrow cell dysplasia in a refractory anemia patient treated with vitamin D3]. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 40(5).

Chicago

N, Wakimoto, Kimura F, Sato K, Kuwada N, Matsumura T, Yamashita T, Nakamura Y, Yoshida M, and Motoyoshi K. 1999. “[Marked Hematologic Improvement despite Deterioration of Marrow Cell Dysplasia in a Refractory Anemia Patient Treated with Vitamin D3].” [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology 40 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........0529eea8ffe6c864acf3621ec7978882&authtype=sso&custid=ns315887.